The PLCO cancer screening trial: Background, goals, organization, operations, results

Reviews on Recent Clinical Trials

Volumn 10, Issue 3, 2015, Pages 173-180

  Gohagan, John K ^a,b   Prorok, Philip C ^c   Greenwald, Peter ^b   Kramer, Barnett S ^c  

^a Office of Disease Prevention and Health Promotion   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer screening trial; Concept; Design; Goals; Management; Operations; PLCO; Results

Indexed keywords

CA 125 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD EXAMINATION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; CHEEK CELL; DIGITAL RECTAL EXAMINATION; FOOD FREQUENCY QUESTIONNAIRE; HEALTH CARE ORGANIZATION; HISTOLOGY; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; LEADERSHIP; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGMOIDOSCOPY; STUDY DESIGN; THORAX RADIOGRAPHY; TRANSVAGINAL ECHOGRAPHY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; LUNG NEOPLASMS; MALE; MOTIVATION; MULTICENTER STUDY (TOPIC); ORGANIZATION; OVARIAN NEOPLASMS; PILOT STUDY; PROCEDURES; PROSTATIC NEOPLASMS; UNITED STATES;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GOALS; HUMANS; LUNG NEOPLASMS; MALE; MULTICENTER STUDIES AS TOPIC; ORGANIZATIONAL INNOVATION; OVARIAN NEOPLASMS; PILOT PROJECTS; PROSTATIC NEOPLASMS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 84946032323     PISSN: 15748871     EISSN: 18761038     Source Type: Journal    
DOI: 10.2174/1574887110666150730123004     Document Type: Article

References (19)

1. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The prostate, lung colorectal and ovarian cancer screening trial of the National Cancer Institute: History, Organization, and Status. Control Clin Trials 2000; 21(Suppl 6S): 251S-72S.
2. Prorok PC, Byar DP, Smart CR, Baker SG, Connor RJ. Evaluation of screening for prostate, lung and colorectal cancers: the PLC trial. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds). Cancer Screening. Cambridge: Cambridge University Press, 1991; pp. 300-20.
3. Prorok PC, Andriole GL, Bresalier R, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21(Suppl 6S): 273S - 309S.
4. Hayes RB, Reding D, Kopp W, et al. Etiology and early marker studies in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21(Suppl 6S): 349S-355S.
5. Simpson NK, Johnson CC, Ogden SL, et al. Recruitment strategies in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first six years. Control Clin Trials 2000; 21(S) (Suppl): 359S.
6. Pinsky PF, Ford M, Gamito E, et al. Enrollment of racial and ethnic minorities in the prostate, lung, colorectal and ovarian cancer screening trial. J Natl Med Assoc 2008; 100(3): 291-8.
7. Gohagan JK, Prorok PC, O'Brien B, et al. Managed multi-centered recruitment in the PLCO cancer screening trial. IN THIS MONOGRAPH.
8. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality in the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011; 305: 2295-303.
9. Hasson MA, Fagerstrom RM, Kahane DC, et al. Design and evolution of the data management systems in the Prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21(Suppl 6S): 329S-46S.
10. Gohagan JK, O'Brien B, Hasson MA, et al. Comprehensive quality management in the PLCO Trial. IN THIS MONOGRAPH.
11. Rozjabek, Marcus. Information management and sharing in the PLCO Cancer Screening Trial. In press.
12. Zhu CS, Pinsky PF, Kramer BS, et al. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst 2013; 105: 1684-93.
13. Carrick DM, Black A, Gohagan JK, et al. The PLCO biorepository: creating, maintaining, and administering a unique biospecimen resource. IN THIS MONOGRAPH.
14. Andriole GL, Grubb RL, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-19.
15. Oken MM, Hocking WG, Kavale PA, et al. Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA 2011; 306(17): 1865- 73.
16. Schoen RE, Pinsky PF, Weissfeld JL, et al. N Engl J Med 2012; 366: 2345-57.
17. Gohagan J, Marcus P, Fagerstrom R, et al. Lung Screening Study Research Group. Baseline findings of randomized feasibility trial of lung cancer screening with spiral CT scan versus chest radiograph: the lung screening study of the National Cancer Institute. Chest 2004; 126: 114-21.
18. Gohagan JK, Marcus PM, Fagerstrom RM, et al. Final results of the lung screening study, a randomized feasibility of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005; 47: 9-15.
19. NLST The National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011; 258: 243-53.